Effect of iridoid glucoside on plasma lipid profile, tissue fatty acid changes, inflammatory cytokines, and GLUT4 expression in skeletal muscle of streptozotocin-induced diabetic rats

Molecular and Cellular Biochemistry

Volumn 380, Issue 1-2, 2013, Pages 43-55

  Sundaram, Ramalingam ^a   Shanthi, Palanivelu ^a   Sachdanandam, Panchanatham ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Diabetes; Fatty acid; Iridoid glucoside; Lipid profiles; Vitex negundo

Indexed keywords

CHOLESTEROL; CYTOKINE; FATTY ACID; GLIBENCLAMIDE; GLUCOSE TRANSPORTER 4; GLYCOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IRIDOID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETES MELLITUS; GAS CHROMATOGRAPHY; INSULIN RELEASE; LIPID BLOOD LEVEL; LIPID COMPOSITION; MALE; NONHUMAN; PLANT LEAF; PROTEIN EXPRESSION; RAT; SKELETAL MUSCLE; STREPTOZOCIN DIABETES; TRIACYLGLYCEROL BLOOD LEVEL; VITEX NEGUNDO;

ANIMALS; BLOTTING, WESTERN; CHOLESTEROL; CYTOKINES; DIABETES MELLITUS, EXPERIMENTAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATTY ACIDS; GLUCOSE TRANSPORTER TYPE 4; GLYBURIDE; HYPOGLYCEMIC AGENTS; INFLAMMATION MEDIATORS; IRIDOID GLUCOSIDES; KIDNEY; LIPIDS; LIVER; MALE; MUSCLE, SKELETAL; PANCREAS; RATS; RATS, WISTAR; TRIGLYCERIDES;

RATTUS; VITEX NEGUNDO;

EID: 84879796284     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-013-1656-0     Document Type: Article

References (59)

1. Scheen JA (1997) Drug treatment of non-insulin dependent diabetes mellitus in the 1990. Achievement and future development. Drug 54:355-368
2. Mohan V, Madan Z, Jha R, Deepa R, Pradeepa R (2004) Diabetes - social and economic perspectives in the new millennium. Int J Diab Dev Countries 24:29-35
3. King H, Aubert R, Herman WH (1998) Global burden of diabetes 1995-2025. Diabetes Care 21:1414-1431
4. Maghrani M, Lemhadri A, Zeggwagh NA, El Amraoui M, Haloui M, Jouad H, Eddouks M (2004) Effects of an aqueous extract of Triticum repens on lipid metabolism in normal and recent-onset diabetic rats. J Ethnopharmacol 90:331-337
5. Manninen V, Tenkanen L, Koskinien P (1992) Joint effects of serum triglycerides and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki heart study: implications for treatment. Circulation 85:37-45
6. Das S, Mohan V (2003) Disorders of lipid metabolism. In: Shah SN (ed) API text book of medicine, 75th edn. Association of physician of India, Mumbai, pp 250-258
7. Bhattaram VA, Ceraefe M, Kohlest C, Vest M, Deundorf H (2002) Pharmacokinetics and bioavailability of herbal medicinal products. Phytomedicine 9:1-36
8. Bailey CJ, Day C (1989) Traditional plant medicines as treatments for diabetes. Diabetes Care 12:553-564
9. Mitra SK, Gopumadhavan S, Muralidhar TS, Anturlikar SD, Sujatha MB (1996) Effect of a herbomineral preparation D-400 in streptozotocin induced diabetic rats. J Ethnopharmacol 54:41-46
10. Annapurna A, Kanaka S, Mahalakshmi D, Murali KK (2001) Antidiabetic activity of a polyherbal preparation (tincture of punchparna) in normal and diabetic rats. Indian J Exp Biol 39:500-502
11. Bhattacharya SK, Satyan KS, Chakrbarti A (1997) Effect of trasina, an Ayurvedic herbal formulation, on pancreatic islet superoxide dismutase activity in hyperglycaemic rats. Indian J Exp Biol 35:297-299
12. The WHO Expert Committee on Diabetes Mellitus. Technical report series 646, Geneva, and World Health Organisation 1980
13. Banerji A, Chadha MS, Malshet VG (1969) Isolation of 5-hydroxy-3,6,7, 3′,4′-pentamethoxy flavone from Vitex negundo. Phytochemistry 8:511-512
14. Suksamaran A, Kumpun S, Kirtikara K, Yingyongnarongkul B, Suksamrarn S (2002) Iridoid with anti-inflammatory activity from Vitex peduncularis. Planta Med 68:72-73
15. Pianaro A, Pinto JP, Ferreira TD, Ishikawa NK, Raimundo Braz-Filho RB (2007) Iridoid glucoside and antifungal phenolic compounds from Spathodea campanulata roots Semina: Ciencias Agrarias. Londrina 28:251-256
16. Sundaram R, Naresh R, Ranadevan R, Shanthi P, Sachdanandam P (2012) Effect of iridoid glucoside on streptozotocin induced diabetic rats and its role in regulating carbohydrate metabolic enzymes. Eur J Pharmacol 674:460-467
17. Sundaram R, Naresh R, Ranadevan R, Shanthi P, Sachdanandam P (2012) Antihyperglycemic effect of iridoid glucoside, isolated from the leaves of Vitex negundo in streptozotocin-induced diabetic rats with special reference to glycoprotein components. Phytomedicine 19:211-216
18. Ramesh B, Pugalendi KV (2006) Antioxidant role of Umbelliferone in STZ-diabetic rats. Life Sci 79:306-310
19. Folch J, Lees M, Solane SGH (1957) A simple method for isolation and purification of total lipids from animal tissues. J Biol Chem 26:497-509
20. Zilversmit DB, Davis AK (1950) Micro determination of phospholipids by TCA precipitation. J Lab Clin Med 35:155-159
21. Falholt K, Falholt W, Lund B (1973) An easy colorimetric method for routine determination of free fatty acid in plasma. Clinica Chimca Acta 46:105-111
22. Morales MA, Jobbagy AJ, Terenzi HF (1973) Mutations affecting accumulation of glycogen. Neurospora News Lett 20:24-25
23. Morrison WR, Smith LM (1964) Preparations of fatty acid methyl esters and dimethylac- etals from lipids with boron fluoride methanol. J Lipid Res 5:600-607
24. Dombrowski L, Roy D, Mareotte B, Marette A (1996) A new procedure for the isolation of plasma membrane, T-tubules and internal membranes from skeletal muscles. Am J Physiol 270:E667-E676
25. Lowry OH, Rosenbrough NJ, Farr AI, Randall RJ (1951) Protein measurement with folin-phenol reagent. J Biol Chem 193:265
26. Stamler JS, Vaccaro O, Neaton D (1993) Wentworth, diabetes, other risk factors and 12 year cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 16:434-444
27. Kanters SDJM, Banga JD, Erkelens DW (2001) Lipid-lowering therapy in diabetes mellitus. Neth J Med 58:214-222
28. Maghrani M, Lemhadri A, Zeggwagh NA, El Amraoui A, Haloui M, Jouad M, Eddouks M (2004) Effect of Retama raetam on lipid metabolism in normal and recent onset diabetic rats. J Ethnopharmacol 90:323-329
29. Rhoads GS, Gulbrandse CL, Kagan A (1976) Serum lipoproteins and coronary artery diseases in a population study of Hawaii, a Japanese man. N Engl J Med 294:293-298
30. Goodman LS, Gilman A (1985) The Pharmacological Basis of Therapeutics, 7th edn. MacMillan, New York, p 490
31. Cameron NE, Cottter MA (1997) Effects of antioxidants on nerve and vascular dysfunction in experimental diabetes. Diabetes Res Clin Pr 45:137-146
32. Pelikanova T, Kohout M, Valek J, Base J, Stefka Z (1991) Fatty acid composition of serum lipids and erythrocyte membranes in type 2 (non-insulin dependent) diabetic men. Metabolism 40:175-180
33. Folsom AR, Ma J, McGovern PG, Eckfeldt H (1996) Relation between plasma phospholipid saturation fatty acids and hyperinsulinemia. Metabolism 45:223-228
34. Vessby B (2000) Dietary fat and insulin actions in humans. Brit J Nutr 83:91-96
35. Ravi P, Dai S, Tam KC (2005) Synthesis and self assembly of [6O] fullerene containing sulfobetaine polymer in aqueous solution. J Phys Chem B Condens Matter Mater. Surf Interfaces Biophys 8:22791-22798
36. Murugan P, Pari L (2007) Protective role of tetrahydrocurcumin on changes in the fatty acid composition in streptozotocin-nicotinamide induced type 2 diabetic rats. J Applied Biomed 5:31-38
37. Demaison L, Sergiel JP, Moreau D, Grynberg A (1994) Influence of the phospholipid n-6/n-3 polyunsaturated fatty acid ratio on the mitochondrial oxidative metabolism before and after myocardial ischemia. Biochimica Biophysica Acta 127:53-59
38. Robertson RP (2004) Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J Biol Chem 279:42351-42354
39. Kaneto H, Kawamori D, Matsuoka TA, Kajimoto Y, Yamasaki Y (2005) Oxidative stress and pancreatic beta-cell dysfunction. Am J Ther 12:529-533
40. Leung PS, Chan YC (2009) Role of oxidative stress in pancreatic inflammation. Antioxid Redox Sign 11:135-165
41. Kaneto H, Matsuoka T, Nakatani Y, Kawamori D, Matsuhisa M, Yamasaki Y (2005) Oxidative stress and the JNK pathway in diabetes. Curr Diabetes Rev 1:65-72
42. Saghizadesh M, Ong JM, Garvey WT, Henry RR, Kern PA (1996) The expression of TNF-α by human muscle. Relationship to insulin resistance. J Clin Invest 97:1111-1116
43. Devaraj S, Jialal I (2000) Antioxidants and vitamins to reduce cardiovascular disease. Curr Atheroscler Rep 2:342-351
44. Halse R, Pearson SL, McCormack JG, Yeaman SJ, Taylor R (2001) Effects of tumor necrosis factor-a on insulin action in cultured human muscle cells. Diabetes 50:1102-1109
45. Kern PA, Ranganathan S, Li C (2001) Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 280:745-751
46. Rui L, Aguirre V, Kim JK, Shulman GI, Lee A, Corbould A, Dunaif A, White MF (2001) Insulin/IGF-1 and TNF- stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. J Clin Invest 107:181-189
47. Singh U, Devraj S, Jialal I (2005) Vitamin E, oxidative stress and inflammation. Annu Rev Nutr 25:151-174
48. Andreozzi F, Laratta E, Cardellini M (2006) Plasma interleukin-6 levels are independently associated with insulin secretion in a cohort of Italian-Caucasian nondiabetic subjects. Diabetes 55:2021-2024
49. Baud V, Karin M (2001) Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol 11:372-377
50. Yudkin JS, Stehouwer CD, Emeis JJ (1999) C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 19:972-978
51. Rosenstock M, Greenberg AS, Rudich A (2001) Distinct long-term regulation of glycerol and non-esterified fatty acid release by insulin and TNF-alpha in 3T3-L1 adipocytes. Diabetologia 44:55-62
52. Cavallo MG, Pozzilli P, Bird C, Wadhwa M, Meager A, Visalli N, Gearing AJ, Andreani D, Thorpe R (1991) Cytokines in sera from insulin dependent diabetic patients at diagnosis. Clin Exp Immunol 86:256-259
53. Hussain MF, Peakman M, Gallati H, Lo SS, Hawa M, Viberti GC, Watkins PJ, Leslie RD, Vergani D (1996) Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM. Diabetologia 39:60-69
54. Rader DJ (2000) Inflammatory markers of coronary risk. N Engl J Med 343:1179-1182
55. Jain SK, Kannan K, Lim G, Matthew-Greer J, McVie R, Bocchini JA (2003) Elevated blood interleukin-6 levels in hyperketonemic type 1 diabetic patients and secretion by acetoacetate-treated cultured U937 monocytes. Diabetes Care 26:2139-2143
56. Peraldi P, Spiegelman B (1998) TNF-alpha and insulin resistance: summary and future prospects. Mol Cell Biochem 182:169-175
57. Wellen KE, Hotamisligil GS (2005) Inflammation, stress, and oxidative stress. J Clin Invest 115:1111-1119
58. Jialal I, Devraj S, Venugopal SK (2004) C-reactive protein: risk marker or mediator in atherothrombosis. Hypertension 44:6-11
59. Kainulainen H, Breiner M, Schurmann A, Marttinen A, Virjo A, Joost HG (1994) In vivo glucose uptake and glucose transporter proteins GLUT1 and GLUT4 in heart and various types of skeletal muscle from streptozotocin-diabetic rats. Biochim Biophys Acta 1225:275-282